Bruker (NASDAQ:BRKR) Rating Lowered to “Hold” at Citigroup
Citigroup lowered shares of Bruker (NASDAQ:BRKR – Free Report) from a strong-buy rating to a hold rating in a research report report published on Thursday morning, Marketbeat.com reports. They currently have $40.00 price target on the medical research company’s stock, down from their prior price target of $50.00. BRKR has been the topic of several […]
Citigroup lowered shares of Bruker (NASDAQ:BRKR – Free Report) from a strong-buy rating to a hold rating in a research report report published on Thursday morning, Marketbeat.com reports. They currently have $40.00 price target on the medical research company’s stock, down from their prior price target of $50.00. BRKR has been the topic of several […]
-corp-logo-1200x675.png?v=20250303130517&w=240&h=240&zc=2){kind=logo}
